Prognostic Impact of Comorbidities on Outcomes of Patients (pts) with Relapsed or Refractory Large B-Cell Lymphoma (r/r LBCL) Treated with Chimeric Antigen Receptor T-Cell Therapy (CART)

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2022-11, Vol.140 (Supplement 1), p.4636-4638
Hauptverfasser:	Greenbaum, Uri, Hashmi, Hamza, Elsawy, Mahmoud, Kim, Soyoung, Moskop, Amy, Awan, Farrukh T., Farooq, Umar, Ganguly, Siddhartha, Hematti, Peiman, Jain, Michael D., Kebriaei, Partow, Locke, Frederick L., Mead, Elena, Nishihori, Taiga, Olson, Amanda L., Pennisi, Martina, Perales, Miguel-Angel, Ramakrishnan Geethakumari, Praveen, Shouval, Roni, Shpall, Elizabeth J., Magalhaes-Silverman, Margarida Magalhaes, Strouse, Christopher, Turtle, Cameron J., Vallurupalli, Anusha, Wudhikam, Kitsada, Pasquini, Marcelo C., Ahmed, Sairah, Sorror, Mohamed
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!